A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.
Resistance to therapy and tumor heterogeneity remain the fundamental drivers of treatment failure in oncology. While single-agent therapies have provided ...
HealthDay on MSN
Women more likely to survive cancer than men — at a cost
Key Takeaways Women are more likely to survive cancer than menHowever, they also are more likely to develop severe side ...
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication romiplostim can effectively prevent chemotherapy from destroying platelet-producing ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it alters gut bacteria and increases levels of a microbial molecule that travels to ...
Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is failing months before evidence shows up on regular scans, allowing oncologists to ...
Intermittent shortages of various injectable chemotherapy drugs have become a regular part of cancer care, with oncology practices reporting that despite their best efforts to mitigate supply ...
Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results